The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A functional measurement of MAPK pathway activation to predict response to MEK inhibitors in RAS-mutated patients.
 
Shumei Kato
No Relationships to Disclose
 
Robert Porter
No Relationships to Disclose
 
Ryosuke Okamura
No Relationships to Disclose
 
Ori Zelichov
Employment - NovellusDx
Leadership - NovellusDx
Stock and Other Ownership Interests - NovellusDx
Patents, Royalties, Other Intellectual Property - NovellusDx (Inst)
Travel, Accommodations, Expenses - NovellusDx
 
Gabi Tarcic
Employment - NovellusDx
Patents, Royalties, Other Intellectual Property - Patents submitted as a NovellusDx employee (Inst)
 
Michael Vidne
Employment - NovellusDx
Leadership - NovellusDx
Stock and Other Ownership Interests - NovellusDx
Patents, Royalties, Other Intellectual Property - NovellusDx (Inst)
Travel, Accommodations, Expenses - NovellusDx
 
Razelle Kurzrock
Leadership - CureMatch
Stock and Other Ownership Interests - CureMatch; IDbyDNA; Soluventis
Consulting or Advisory Role - Actuate Therapeutics; Gaido; Loxo; NeoMed; Roche; Soluventis; XBiotech
Speakers' Bureau - Roche
Research Funding - Foundation Medicine (Inst); Genentech (Inst); Grifols (Inst); Guardant Health (Inst); Incyte (Inst); Konica Minolta (Inst); Merck Serono (Inst); OmniSeq (Inst); Pfizer (Inst); Sequenom (Inst)